Ideaya aims to raise $263M; Immuneel extends Series A with $12M

Plus, news about XyloCor, Pfizer, Evotech, Skyhawk Therapeutics, HepaRegeniX and Vyome:

Ideaya Biosciences’ $263M public offering: The South San Francisco, CA-based biotech said Tuesday it will sell more than seven million shares at $35 apiece in addition to pre-funded warrants. The offering is expected to close Thursday. — Ayisha Sharma

Immuneel Therapeutics raises $12M in Series A extension: The funds will be used to support the Indian CAR-T cell therapy company’s growth and expansion, according to an exclusive report by Entrackr, a news site that covers startups. Immuneel aims to bring cell and gene therapies for cancer to non-Western markets at a fraction of current prices. — Ayisha Sharma

XyloCor licenses catheter device for heart drugs: The company will use the device to help develop “catheter-based endocardial delivery” of its heart gene therapy, called XC001….
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks